Canton, Mass. (PRWEB) March 06, 2014
The Association of Strategic Alliance Professionals (ASAP), the world’s leading professional association dedicated to the practice of alliance management, today announced that leading pharmaceutical company Astellas Pharma Inc. has upgraded to Global Member.
Astellas, a long-time corporate member of ASAP, is deepening its engagement with ASAP to further reinforce the company’s efforts to elevate the practice of alliance management—particularly within the healthcare industry.
“Strategic partnerships are critically important in enabling Astellas to meet the unmet medical needs of patients around the world through innovative and reliable pharmaceutical products,” said Chihiro Yokota, Global Head of Business Development and Licensing & Alliances for Astellas. “Our membership in ASAP strengthens our ability to collaborate effectively and helps Astellas maximize the value of our partnerships.”
Astellas has been a long-time contributor and influential presence within the ASAP community. For example, Percival Barretto-Ko, Astellas’ Senior Vice President of Corporate Strategy and Government Affairs, was featured as the keynote presenter at the 2012 ASAP BioPharma Conference—reflecting the commitment of Astellas’ senior leadership to strategic partnering, to ASAP, and to the development of the alliance management discipline.
Astellas is utilizing ASAP in a number of ways. Astellas alliance managers obtain and maintain certification in current alliance management practices and methodologies. Astellas sends its professionals to global ASAP events such as the ASAP BioPharma Conference and ASAP Global Alliance Summit. In addition, as an ASAP Global Member, Astellas will have the opportunity to add executives from its partner organizations to its membership roster, thereby giving them access to ASAP benefits, including:
“Partnerships are essential to the future of the biopharmaceutical industry—and Astellas’ increased commitment to ASAP helps this association support the ever-expanding wave of partnership and collaboration sweeping across life sciences, healthcare, and virtually every other industry and sector,” said Michael Leonetti, President and CEO of ASAP. “Astellas and other leading alliance management practitioners turn to ASAP for the learning, community, and tools they need to achieve their most critical strategic goals. We are proud to play an important role in helping Astellas maximize the value and performance of its strategic partnerships.”
The Association of Strategic Alliance Professionals (ASAP) is the only professional association dedicated to elevating and promoting the profession of alliance management. Founded in 1998, the organization provides professional development, networking and resources for cultivating the skills and toolsets needed to manage successful business partnerships. Active global members include AbbVie, Astellas, AstraZeneca, CA Technologies, Capgemini, Cisco, Citrix, Covance, Dell, Eli Lilly and Company, IBM, the Janssen Pharmaceutical Companies, KPMG, Microsoft, Motorola, Novartis, Sanofi, SAS, Schneider Electric, Verizon, VMware, The Warren Company, and Xerox. A complete list of global members is available at http://www.strategic-alliances.org.
Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. For more information on Astellas Pharma Inc., please visit the company website at http://www.astellas.com/en.